000 | 01705 a2200433 4500 | ||
---|---|---|---|
005 | 20250515151301.0 | ||
264 | 0 | _c20090122 | |
008 | 200901s 0 0 eng d | ||
022 | _a1520-4804 | ||
024 | 7 |
_a10.1021/jm8007689 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBolognese, Adele | |
245 | 0 | 0 |
_aAntitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cDec 2008 |
||
300 |
_a8148-57 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 | _aCatalysis |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 |
_aChemistry, Pharmaceutical _xmethods |
650 | 0 | 4 |
_aDNA _xchemistry |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aQuinolines _xchemical synthesis |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aTopoisomerase II Inhibitors |
700 | 1 | _aCorreale, Gaetano | |
700 | 1 | _aManfra, Michele | |
700 | 1 | _aEsposito, Anna | |
700 | 1 | _aNovellino, Ettore | |
700 | 1 | _aLavecchia, Antonio | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 51 _gno. 24 _gp. 8148-57 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm8007689 _zAvailable from publisher's website |
999 |
_c18508111 _d18508111 |